Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy

Summary by Charleston Gazette-Mail
DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a novel fusion protein in Cell Reports Medicine. The peer-reviewed…

64 Articles

Bennington BannerBennington Banner
+63 Reposted by 63 other sources
Center

Fapon Biopharma Publishes Pioneering Research in Cell Reports Medicine on FP008, an anti-PD 1 X IL-10M Fusion Protein for Cancer Immunotherapy

DONGGUAN, China, Dec. 23, 2025 /PRNewswire/ -- Fapon Biopharma, a biotech in developing therapeutic biologics including cytokine-antibody fusion proteins and T-cell engagers, announced the publication of pioneering research on FP008, a novel fusion protein in Cell Reports Medicine. The peer-reviewed…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources are Center
63% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Tuesday, December 23, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Dongguan icon

Dongguan

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal